Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume - Here's What Happened

Key Points

• Nihon Kohden experienced an unusually large intraday volume surge to approximately 227,506 shares (a 907% increase from the prior session), with the stock last trading at $9.3650 versus a prior close of $9.6020.
• UBS upgraded the stock from "hold" to "strong-buy" on January 19, and MarketBeat shows the consensus analyst rating as Strong Buy.
• The company reported $0.16 EPS on $362.86M in revenue (net margin 5.32%, ROE 7.25%); Nihon Kohden has a market cap of $1.60B, a PE of 18.39, and its 50- and 200-day moving averages are both about $11.2.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 227,506 shares traded hands during mid-day trading, an increase of 907% from the previous session's volume of 22,601 shares.The stock last traded at $9.3650 and had previously closed at $9.6020.

Analyst Ratings Changes

Separately, UBS Group raised Nihon Kohden from a "hold" rating to a "strong-buy" rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, Nihon Kohden currently has an average rating of "Strong Buy".

Nihon Kohden Price Performance

The company's fifty day simple moving average is $11.19 and its 200-day simple moving average is $11.26. The firm has a market capitalization of $1.60 billion, a PE ratio of 18.39 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last released its earnings results on Thursday, February 5th. The company reported $0.16 EPS for the quarter. The business had revenue of $362.86 million during the quarter. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan's earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company's core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.